Chen C.-B.Hsiao Y.-H.Wu T.Hsih M.-S.Tassaneeyakul W.Jorns T.P.Sukasem C.Hsu C.-N.Su S.-C.Chang W.-C.Hui R.C.-Y.CHIA-YU CHUChen Y.-J.Wu C.-Y.Hsu C.-K.Chiu T.-M.Sun P.-L.Lee H.-E.Yang C.-Y.Kao P.-H.Yang C.-H.Ho H.-C.Lin J.-Y.Chang Y.-C.Chen M.-J.Lu C.-W.Ng C.Y.Kuo K.-L.Lin C.-Y.Yang C.-S.Chen D.-P.Chang P.-Y.Wu T.-L.Lin Y.-J.Weng Y.-C.Kuo T.-T.Hung S.-I.Chung W.-H.For the Taiwan Severe Cutaneous Adverse Reaction Consortium2019-12-042019-12-0420170028-3878https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007043728&doi=10.1212%2fWNL.0000000000003453&partnerID=40&md5=7b0f25017d6fd02f8cc3244a720047dfhttps://scholars.lib.ntu.edu.tw/handle/123456789/434882Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asiansjournal article10.1212/WNL.0000000000003453279136992-s2.0-85007043728